Michigan Diabetes Drug Side Effects Lawsuits

Michigan Lawsuits for Diabetes Drug Heart Attack, Cancer, and Infection

If you or a loved one developed serious diabetes drug side effects in Michigan, you may eligible to file a diabetes drug lawsuit against drug manufacturers. Michigan diabetes drug claims and associated lawsuits give persons and families harmed by diabetes drug problems in Michigan the means to seek compensation for damages caused by unsafe or recalled medications.

Today, over 30 million people in the United States live with diabetes and require the aid of medications to control their blood sugar levels, including thousands of Michigan residents. At least 16 diabetes drugs have been linked to serious side effects, either resulting in strict, new warnings or recalls. These medications include Invokana, Victoza, Avandia, Actos, Farxiga, Xigduo XR, Qtern, Jardiance, Glyxambi, Synjardy, Synjardy XR, Invokamet, Invokamet XR, Steglatro, Segluromet, and Stelujan. Persons in Michigan who have taken any of these drugs and suffered from conditions including limb amputation, bladder and pancreatic cancer, heart attack and other cardiovascular problems, kidney disease, ketoacidosis, and the severe genital infection known as Fournier's Gangrene may have legal grounds to file a diabetes drug problems lawsuit for Michigan residents.

Diabetes Drug Lawsuits for Necrotizing Fasciitis in Michigan

Most people agree they would rather avoid getting involved in a lawsuit, particularly if they are grappling with major health problems or financial stress. While it may seem stressful or unlikely to pan out in your favor, filing a diabetes drug lawsuit is the best means to get your family back on track financially. It is our belief that persons having suffered from serious diabetes drug problems in Michigan, with no warning of the risk, deserve and require compensation for the medical expenses, harm, and suffering resulting from diabetes drug defects. What some residents of Michigan find even more appealing is the opportunity to bring accountability to a multinational pharmaceutical corporation, perhaps effecting positive change and better regulating a dangerous drug.

Our attorneys will represent all Michigan plaintiffs in diabetes drug infection lawsuits and are now offering free, no-obligation diabetes drug lawsuit case review to persons and family members of persons who developed the following diabetes drug problems in Michigan:

• Invokana limb amputation or other Invokana side effects including ketoacidosis, kidney failure, bone fracture, heart attack, stroke
• Victoza pancreatic cancer, Victoza ketoacidosis, Victoza limb amputation
• Actos bladder cancer
• Avandia heart attack
• Farxiga / Xigduo ketoacidosis and kidney damage
• Fournier's gangrene from any of the following diabetes drugs: Invokana, Invokamet, Invokamet XR, Farxiga, Xigduo XR, Qtern, Jardiance, Glyxambi, Synjardy, Synjardy XR, Steglatro, Segluromet, Stelujan

Diabetes drug problems in Michigan residents can result in life-threatening complications requiring significant medical care and may result in permanent damage or death. To discuss your circumstances in detail with an attorney and to learn about Michigan diabetes drug infection lawsuit time limits, please complete our online contact form or contact our firm. One of our attorneys handling diabetes drug lawsuits for Michigan residents will be in contact shortly to discuss your case and answers your questions.

Michigan Diabetes Drug Lawsuits Are Not Class Action Lawsuits

Michigan diabetes drug lawsuits will not be class action lawsuits, where plaintiffs receive only a symbolic settlement. In fact, filing a diabetes drug claim in Michigan is the only means to hold manufacturers accountable for the damage these dangerous drugs have caused – and is the only way to obtain the compensation you deserve for medical expenses, lost wages, harm and suffering. Attorneys for diabetes drug lawsuits believe Michigan plaintiffs may be entitled to significant compensation. Often in cases where a drug has caused significant harm to many people, the cases are consolidated as Multi-District Litigation (MDL), which accelerates the legal process while still preserving the facts of each case. This has already occurred in some diabetes drug lawsuits:

• Actos Bladder Cancer Lawsuits – MDL 2299 was closed in April, 2018, after six years, with a settlement amount of $2.37 billion
• Avandia Heart Attack Lawsuits – MDL 1871 settled 50,000 cases for more than $3.4 billion; drugmaker GlaxoSmithKline failed to warn patients of the risk of heart attack from Avandia.
• Farxiga Ketoacidosis Lawsuits and Xigduo XR Kidney Damage Lawsuits – MDL 2775, currently underway in New York with more than 50 cases
• Invokana Ketoacidosis, Heart Attack, Stroke, and Severe Kidney Damage Lawsuits – MDL 2750 filed in 2017 in U.S. District Court in New Jersey
• Onglyza and Kombiglyze XR Heart Failure Lawsuits – MDL 2809 currently underway in Kentucky with approximately 100 cases involving Heart Failure, Myocardial Infarction, and other Cardiovascular Problems
• Victoza Pancreatic Cancer Lawsuits – MDL 2452, currently underway in California with more than 350 cases
• Victoza Lawsuits for Ketoacidosis - MDL 2750, MDL, currently underway in New Jersey

You can be assured that when cases are consolidated as MDL, compensation will be determined by the unique factors in each case and the degree of suffering encountered by each plaintiff.